Introduction
TLR4 is a pattern recognition receptor (PRR) that initiates the innate immune response against Gram-negative bacteria infection by recognizing LPS, the prominent component of the bacteria cell wall 1 . The role of TLR4 and its signaling pathway has been extensively studied in macrophages, as these cells abundantly express TLR4 and are crucial players in LPS-induced immune responses 2, 3 . In response to infection by Gramnegative bacteria, resident macrophages recognize LPS via surface TLR4 1 , process the pathogen, migrate to the regional draining lymph node and present the antigen to T lymphocytes, resulting in induction of the adaptive immune response [4] [5] [6] . During this process, TLR4 activates NF-κB, a canonical transcription factor that mediates various inflammatory responses, which results in the activation of a variety of pro-inflammatory genes in macrophages 4, [7] [8] [9] .
TLR4 is also expressed in non-immune cells, including those that constitute the vascular system 10, 11 . The lymphatic vessel has a specialized structure distinct from blood vessels in several aspects. LEC, a major cell type in lymphatic vessels, express specific markers, respond to different growth factors, and constitute blind-ended loose initial lymphatic capillary [12] [13] [14] [15] . Moreover, the function of the lymphatic vessel is unique in that it absorbs macromolecules, transports interstitial fluid, and orchestrates proper trafficking and recirculation of immune cells to the regional lymph node where the adaptive immune response occurs 16, 17 . However, despite the demonstrated function of the lymphatic vessel as a major player in several immune responses, the details on the expression level, signaling pathway, and precise role of TLR4 in LEC remain unknown.
only.
For personal use at PENN STATE UNIVERSITY on . bloodjournal.hematologylibrary.org From . 4 De novo lymphangiogenesis occurs mainly by proliferation/migration of LEC from preexisting lymphatic vessels 13 . Recent reports [18] [19] [20] [21] indicate that lymphangiogenesis occurs largely by the paracrine effect of abundantly infiltrated macrophages, suggesting a crucial role of macrophages for lymphangiogenesis. However, little is known about the mechanism by which macrophages are recruited to the remodeling lymphatic vessel, particularly in the Gram-negative bacteria-induced inflammatory condition. Although recent papers have reported the expression of TLR4 in LEC 22, 23 , the in vivo role of TLR4 in LEC is poorly understood, not only in the aspect of immune cell transport but also in the aspect of inflammatory lymphangiogenesis.
In this study, we investigated the role of TLR4 in LEC using the LPS-induced peritoneal inflammation model that mimics peritoneal Gram-negative bacteria infection.
We compared LPS-induced lymphangiogenesis between C3H/HeN (HeN, normal TLR4 signaling) and C3H/HeJ (HeJ, defective TLR4 signaling) mice 24 . To define the role of LEC specific TLR4 during LPS-induced lymphangiogenesis, we generated chimeric 'N/J' (bone marrow cells (BMC) of HeJ was replaced with BMC from HeN) mice 10 and, as a control, 'N/N' (BMC of HeN was replaced with BMC from HeN) mice. We also investigated the role of TLR4 in LEC on macrophage chemotaxis using the in vitro transwell migration assay and the adoptive cell transfer experiment in vivo 25 . Our results indicate that TLR4 in LEC play a key role in LPS-induced lymphangiogenesis, mainly by chemotactic recruitment of macrophages to the lymphatic vessels.
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Materials and Methods

Mice and LPS treatment
Pathogen-free C3H/HeN (HeN: normal TLR4 signaling mice) and C3H/HeJ (HeJ: mice with a TLR4 gene missense mutation, thus defective in TLR4 signaling) mice 24 were purchased from SLC Incorporation (SLC Inc., Shizuoka, Japan). TLR4 KO mice in C57BL/6 background 3 were donated by Dr. Seung-Hyun Han (Seoul National University, originally provided by S. Akira, Osaka University, Osaka, Japan). C57BL/6 mice were purchased from Jackson Laboratory (Bar Harbor, ME 
Cell culture and LPS treatment
HEK-293A and THP-1 cells were purchased from American Type Culture Collection (ATCC, Manassas, VA) and maintained in Dulbecco's Modified Eagle's Medium (DMEM) and RPMI 1640 medium, respectively, with 10% FBS. BEC (primary blood microvascular endothelial cell derived from human adult dermis) and LEC (primary lymphatic microvascular endothelial cell derived from human adult dermis) were purchased from Cambrex Inc. (East Rutherford, NJ) and maintained in endothelial cell basal medium-2 with growth supplements (EBM-2 MV). Passage four to six cells were used. LPS was diluted with the appropriate basal culture media containing 2% FBS without other supplements and added to the cells, which were pre-incubated in serumdeprived media for 8 hr. Mice LEC were isolated from the peritoneal lymphangioma model according to the previous report 28 , and were maintained and cultured in EBM-2 MV up to passage 3. The purity of mice LEC was >90%, which was verified by double immunofluorescence staining of Prox-1 and CD31.
TLR4 knock down by siRNA transfection
LEC (~50% confluence in a 6 well plate) were transfected with 180 pmol of TLR4 specific siRNA (Santa Cruz Biotechnology, Santa Cruz, CA), 180 pmol of non-specific scramble (sc) RNA (Santa Cruz Biotechnology), or control dilution buffer using XtremeGene siRNA transfection reagent (Roche Applied Science, Indianapolis, IN).
After 48 hrs of transfection, cells were used for experiments as indicated. Table 1 ). Gene expression was normalized against levels of human or mouse GAPDH.
Immunostaining, morphometric analysis and flow cytometric analysis
Immunostaining, morphometric analysis and flow cytometric analysis were performed as described in Supplemental Methods. 
Flow cytometric analysis
Adoptive cell transfer and macrophage depletion
To harvest peritoneal macrophages, 1 ml of 3% thioglycollate was injected intraperitoneally into HeN mice. After 3 days of injection, the peritoneal macrophages were collected by peritoneal washing with PBS. After RBC lysis, the cells were tagged with CFSE green dye (Molecular Probes) and counted. CFSE tagged cells (~2×10 The mice were bred in microisolator cages for 2 months prior to the experiments.
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Statistics
Values are presented as means ± standard deviation (SD). Significant differences between the means were determined by analysis of variance followed by the StudentNewman-Keuls test. Statistical significance was set at P<0.05. Immunofluorescent analysis revealed that TLR4 was abundant and mainly localized as only.
For personal use at PENN STATE UNIVERSITY on February 23, 2013. bloodjournal.hematologylibrary.org From granules in the intracellular area in LEC ( Figure 2B) . In BEC, a lesser amount of TLR4 was mainly localized in the intracellular-perinuclear area as granules, whereas TLR4 localized as granules largely at the cell surface in THP (Figure 2B ), consistent with a previous report 11 . No detectable TLR4 signal was found in HEK. To further define the localization of TLR4 in LEC, flow cytometric analysis was next performed. THP showed both surface and intracellular TLR4 expression, whereas most of TLR4 were detected in the intracellular compartment in LEC and BEC ( Figure 2C ). In addition, LEC incubated with FITC-LPS generated a positive signal for binding, while no binding was observed with HEK ( Figure 2D ), suggesting that LEC have a functional binding receptor for LPS, such as TLR4. Together these suggest that LEC express a high amount of TLR4, mainly in the intracellular area, and that this TLR4 may function as an internal receptor for LPS.
TLR4 in LEC is a functional receptor mediating LPS-induced NF-κB signaling. As NF-κB signaling is one of the major pathways that convey LPS-TLR4-mediated inflammation in macrophages 32 , the interactions among LPS, TLR4, and NF-κB signaling were examined in primary cultured LEC. LPS treatment produced a marked intranuclear translocation of p65, a subunit of NF-κB ( Figure 3A) and a substantial increase in phosphorylation of the NF-κB inhibitor, IκB-α, in a time-dependent manner ( Figure 3B) . Intriguingly, upon LPS stimulation, ~93% of LEC exhibited nuclear localization of p65, whereas just ~41% of BEC did (Figure 3C-D) , indicating that activation of NF-κB signaling in response to LPS is more sensitive in LEC than BEC.
To determine whether LPS-induced NF-κB signaling activation is mediated through TLR4 in LEC, we used TLR4 specific siRNA (siTLR4) to knockdown TLR4 in LEC only.
For personal use at PENN STATE UNIVERSITY on February 23, 2013. bloodjournal.hematologylibrary.org From ( Figure 3E) . Upon LPS stimulation, ~25% of siTLR4-transfected LEC exhibited nuclear localization of p65, whereas ~90% of control-and ~86% of scTLR4-(nonspecific scrambled siRNA) transfected LEC exhibited nuclear localization of p65 ( Figure 3F-G) , indicating that TLR4 is essential for LPS-induced NF-κB signaling activation in LEC. We also analyzed the activity of NF-κB in vivo using a reporter mouse expressing lacZ under control of the p105 promoter, which contains three NF-κB responsive elements 26 . Upon NF-κB activation in these mice, one of the NF-κB subunits, p65, translocates to the nucleus and binds the p105 promoter, which induces lacZ expression. Consistent with a previous report 33 , NF-κB was predominantly expressed in LYVE-1 + lymphatic capillaries but not in the blood vessel of the diaphragm ( Figure S4, upper panel) . Moreover, the LPS-induced, newly developed branching lymphatic vessels also expressed NF-κB ( Figure S4, lower panel) . These data suggest that TLR4-NF-κB signaling in LEC could be a crucial pathway that conveys LPS-induced inflammation and lymphangiogenesis both in vitro and in vivo. For and CCL5 protein levels in the culture media of human LEC in dose-dependent and TLR4-dependent manners (Figure 4D-E) . Notably, LPS treatment (5,000 ng/ml) increased the level of CCL2 protein from ~29 ng/ml up to ~780 ng/ml for 48 hr.
LPS-TLR4
Consistent with these findings, LPS treatment (500 ng/ml for 4 hr) increased the level of Figure S6B) . Moreover, expression of CCL2 was markedly up-regulated in the diaphragmatic lymphatic vessels by LPS treatment in HeN mice, whereas it was not changed in the diaphragmatic lymphatic vessels by LPS treatment in HeJ mice ( Figure   S6C ). We further determined the chemotactic activity of the secreted chemokines from LPS-stimulated LEC using a transwell migration assay ( Figure 4F) . The media supernatant from LEC stimulated with different concentrations of LPS (0-5,000 ng/ml) for 48 hr increased the chemotactic migration of THP-1 monocyte in a dose-dependent manner ( Figure 4G) . Notably, the chemotactic migration of monocytes was reduced when monocytes were incubated with media supernatant from siTLR4-transfected LEC compared to control-or scTLR4-transfected LEC with LPS stimulation (Figure 4H ).
These data indicate that TLR4 signaling in LEC is critical for LPS-induced upregulation of chemokines for trafficking and chemotactic migration of macrophages. only.
Discussion
Here we found that TLR4 in LEC plays a key role in LPS-induced inflammatory lymphangiogenesis by enhancing the recruitment and infiltration of macrophages around lymphatic vessels. LEC actively participates in these processes by producing major chemokines through the LPS-TLR4-NF-κB signaling pathway, and the macrophages recruited to the lymphatic vessels by chemotactic stimuli from LEC act as the major source of lymphangiogenic growth factors, including VEGF-C and VEGF-D (Figure 7) . Taken together, our findings not only clarify the mechanism of the role of TLR4 in LEC involvement in LPS-induced inflammatory lymphangiogenesis, but also highlight close functional interactions between LEC and macrophages in these processes.
We observed profound changes in the lymphatic vessels in response to LPS stimulation in HeN mice with normal TLR4 signaling, whereas almost no changes were observed in in HeJ mice with defective TLR4 signaling. This striking difference led us to explore the role of TLR4 in LEC in LPS-induced inflammatory lymphangiogenesis at in vitro and in vivo levels. Intriguingly, a significant amount of TLR4 was expressed in the intracellular area of LEC and LPS was able to bind to the intracellular TLR4, even though the functional implication of this sub-cellular localization warrants future investigation. Furthermore, LPS-TLR4-NF-κB signaling was ~2 fold more sensitive in LEC than in BEC and NF-κB signal was constitutively active in the diaphragmatic lymphatic but not blood vessels in κ B-lacZ mice. This constitutive and active NF-κB signaling in the lymphatic vessels might be the result of high expression and activation only.
For
of TLR4 and other pattern recognition receptors by various agonists including various
Gram-bacteria, which are the main normal flora of the peritoneal cavity. These results clearly indicate that the LEC is a crucial cell type responding sensitively to LPS.
Immune cells, including monocytes/macrophages, are major cell types that respond to pathogen-induced inflammation and also use TLR4-NF-κB signaling upon LPS stimulation for maturation and mobilization to DLN during the adaptive immune response 4, 41 . Recently, growing evidence has shown that non-immune cells, such as platelet 42 , fibroblast 43, 44 , pulmonary epithelial cells 45 , and BEC 11 also have functional TLR4, which mediates the production of various inflammatory mediators by LPS.
Based on the high levels of TLR4 and the sensitive activation of NF-κB signaling in LEC compared to BEC upon LPS stimulation, the lymphatic vessel may not just be a passive conduit for immune cell transport, but may also be one of the active players in immune modulation.
Because we also observed marked infiltration of CD11b + macrophages around the lymphatic vessels by LPS stimulation in HeN mice, compared to nearly no infiltration in HeJ mice, we hypothesized that TLR4 in LEC may function as a recruiter of macrophages by secreting chemokines upon LPS stimulation. Therefore, we analyzed the expression and production levels of major chemokines for macrophages, such as CCL2, CCL5 and CX3CL1 [34] [35] [36] [37] [38] [39] [40] , in cultured LEC derived from human, and HeN and HeJ mice. Interestingly, our data showed that LPS induced a robust increase in production of the chemokine mRNAs in a TLR4-dependent manner. In addition, our in vitro transwell migration assay and in vivo adoptive cell transfer experiment revealed that the chemotactic migration of macrophages to LEC is largely dependent on TLR4
For personal use at PENN STATE UNIVERSITY on February 23, 2013. bloodjournal.hematologylibrary.org From signaling in LEC. Macrophages are also known as a major supplier for the production of chemokines during LPS-induced inflammation 46, 47 . Therefore, LEC and macrophages may closely interact for the production of chemokines on the recruitment and infiltration of immune cells including macrophages to draining lymphatic vessels during LPSinduced inflammation (Figure 7) .
Our in vitro data in Figure S3 argue against the idea that LPS-TLR4 pathway in LEC may directly induce lymphangiogenesis in a cell-autonomous manner. Rather, LPS-TLR4 pathway in LEC indirectly induces lymphangiogenesis by the production of major chemotactic factors for macrophages that were able to secrete lymphangiogenic factors. Our data clearly revealed that TLR4 in LEC is essential in this scenario, as
shown by marked reductions in LPS-induced chemokine expression and production in the primary cultured human LEC knocked down for TLR4, LEC from the HeJ mouse, and lymphatic vessels in the HeJ mouse. Interestingly, the contribution of lymphatic vessels on macrophage trafficking also affected the lymphatic vessels, resulting in robust lymphangiogenesis by lymphangiogenic growth factors secreted from the infiltrated macrophages. In support of this, our data showed that LPS-stimulated peritoneal macrophages expressed significant amounts of VEGF-C and VEGF-D. For personal use at PENN STATE UNIVERSITY on February 23, 2013. bloodjournal.hematologylibrary.org From lymphangiogenesis may play an important role in draining inflammatory macromolecules, immune cells and debris from inflamed tissues.
The incidence of fatal Gram-negative bacterial sepsis is increasing in proportion to the growing numbers of immune compromised patients 48 . Several new drugs are currently being developed to treat this, including TLR4 blocking agents 49 . In the past, TLR4 in 'effector cells' such as macrophages were considered the main target of these drugs 50 .
However, as 'conduit cells' for immune cell transport, the active contribution of LEC in LPS-induced inflammation in our study implies that the control and modulation of TLR4 function in LECs can be a potential and novel alternative target to overcome
Gram negative bacteria induced mortality.
In conclusion, TLR4 in LEC is an essential molecule in the production of major chemokines for macrophages and in the subsequent recruitment of macrophages to the lymphatic vessel during LPS-induced lymphangiogenesis. In addition, the macrophages induced to infiltrate by the LPS-TLR4 pathway in LEC contribute to robust lymphangiogenesis ( Figure 7) . These TLR4-mediated interactions between LEC and macrophages are central mechanisms in the innate/adaptive immune response and pathogen clearance. 
